Eulerpool Terminal
The edge that pays for itself.
Current Harbin Pharmaceutical Group Co forecasts and price targets in August 2026
Ø Analyst Price Targets
4.71 CNY
-47.11 %
Median
4.71 CNY
-47.11 %
Max
4.85 CNY
Min
4.67 CNY
Last Price
8.91 CNY
Buy
4
Hold
1
Sell
0
The average target price for Harbin Pharmaceutical Group Co is 4.71 CNY. (-47.11 % below the current price)
The median price target of Harbin Pharmaceutical Group Co is 4.71 CNY.
Stock analysts from many renowned investment banks are closely examining the Harbin Pharmaceutical Group Co stock. They conclude their professional Harbin Pharmaceutical Group Co stock analyses with a clear recommendation for the Harbin Pharmaceutical Group Co stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 4 | 1 | 0 | — |
| 2026-02-01 | 4 | 1 | 0 | 4.71 CNY |
| 2026-02-01 | 4 | 1 | 0 | 4.71 CNY |
| 2026-01-01 | 5 | 1 | 0 | 4.71 CNY |
| 2025-12-01 | 5 | 1 | 0 | 4.71 CNY |
| 2025-12-01 | 5 | 1 | 0 | 4.71 CNY |
Harbin Pharmaceutical Group Co Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Harbin Pharmaceutical Group Co in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 18.17 B CNY | 654.00 M CNY | 0.26 CNY |
| 2026e | 16.40 B CNY | 453.00 M CNY | 0.18 CNY |
| 2027e | 16.94 B CNY | 528.00 M CNY | 0.21 CNY |